Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Veradigm ( (MDRX) ) has issued an update.
On December 31, 2025, healthcare technology firm Veradigm Inc. extended Interim Chief Financial Officer Leland Westerfield’s employment term through June 30, 2026, following prior extensions that had already prolonged his interim role beyond the original June 2024 end date. Under the latest agreement, if Westerfield’s employment ends other than for cause or without good reason on his part, and subject to certain conditions, he will continue to receive base salary through December 31, 2026, while the company proceeds with a search for a permanent chief financial officer via a nationally recognized executive search firm, signaling a continued transitional phase in its finance leadership.
The most recent analyst rating on (MDRX) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Veradigm stock, see the MDRX Stock Forecast page.
More about Veradigm
Average Trading Volume: 167,203
Technical Sentiment Signal: Strong Sell
Current Market Cap: $495.5M
Learn more about MDRX stock on TipRanks’ Stock Analysis page.